Clinical Lab Products Magazine

New multicenter study data reveal that targeted sepsis testing at triage in the emergency department (ED) may be key to preserving inpatient bed capacity for the most severe patients. buff.ly/cEXV2vL

Roche is presenting new data from its Alzheimer’s development portfolio at the Alzheimer’s Association International Conference. buff.ly/GLw21fl

CLP asked industry leaders what's in store for clinical diagnostics in the decade after the end of the pandemic. Find out where they think the industry is headed. buff.ly/Qk3ubnb

It's been five years since the declaration of the worldwide COVID-19 pandemic. Find out what laboratory leaders have learned since 2020 as they both look back and look ahead. buff.ly/6mhR8VD

In the age of antibiotic resistance, prompt diagnosis of sepsis is critical to begin treatment as soon as possible. Find out the best practices you can use to speed diagnosis and beat the clock. buff.ly/whJUJ82

CLP Editor Chris Wolski poses the question: Are we headed for a Pandemic Redux? Find out if you should start worrying and preparing now. #pandemic #CLP buff.ly/24Z22DG

🚨 Prostate Cancer Screening Breakthrough 🚨 A new blood test uses protein biomarkers to more accurately predict the need for prostate biopsies. Unlike traditional PSA tests, which often lead to false positives, the test minimizes overdiagnosis. Read: buff.ly/40TSoF7

🔬 AI is revolutionizing clinical labs, boosting efficiency, and enabling personalized medicine through advanced diagnostic models. But challenges like infrastructure updates and workforce training must be addressed. Is your lab ready for AI? buff.ly/4asUoqM

🌍 What Can We Learn from Cuban Healthcare? 🇨🇺🇺🇸 Following a trip to Cuba, CLP Chief Editor Chris Wolski gained a more nuanced view of the Cuban healthcare system, recognizing strengths in universal access and preventive care despite notable challenges. buff.ly/3E1sru8

🧪 Is There a Smart Path to Regulating LDTs? 🔬 With the 2024 election and recent Supreme Court decisions reshaping the regulatory landscape, there is an opportunity for Congress to get the FDA’s Final Rule on LDTs right in 2025. 👉 Read here: buff.ly/3WiIsSK

🔬 CAP’s 2024 Laboratory Accreditation Program 🧪 The 2024 CAP Laboratory Accreditation Program checklists bring major updates to ensure labs meet high standards in quality and compliance. 💡 Learn about the updates and how they impact your lab here: buff.ly/40oZAJ6

Exagen added new biomarkers to its AVISE CTD platform, enhancing diagnostic accuracy for systemic lupus erythematosus and rheumatoid arthritis. Improved sensitivity and specificity mean earlier detection and brighter outcomes for autoimmune patients. 🌟 buff.ly/4a4QYKQ

🚨 Top 17 Lab Trends for 2025: What's Driving Innovation? 🚨 From automation to AI and beyond, lab experts reveal the key trends shaping the future of diagnostics. Discover the full list of trends shaping the labs of tomorrow. 🧪📊 buff.ly/3BIUw8V #LabTrends2025

🌟 Is AI the Future of Diagnostics? 🌟 💡 AI is reshaping clinical labs, enhancing efficiency, improving diagnostic accuracy, and enabling personalized medicine, but also comes with challenges. 🔗 Find out how AI will impact labs and personalized medicine.buff.ly/3CKMtZ4

🚨 Top Clinical Lab Trends for 2025 🚨 Industry experts spotlight 17 trends shaping the future of labs—featuring advancements in digital solutions, self-collection testing, and molecular diagnostics. 🧠 Find out what’s driving the latest trends here: buff.ly/3Z7Iq1R

🧪 Is Social Stigma Holding Back Syphilis Testing? 🧪 CLP explores how social stigma surrounding syphilis may be impacting testing rates. Despite advances in testing accessibility, fear and judgment still play a role in keeping people from getting tested. buff.ly/3O4W2Vt

Join Meridian Bioscience for an exclusive, expert-led webinar featuring gastroenterologists Dr. Steven F. Moss (Brown University) and Dr. Colin W. Howden (University of Tennessee) covering the updated 2024 ACG clinical practice guidelines for H. pylori! buff.ly/4fFaW09

📢 In Case You Missed It! 📢 In this edition of Clinical Lab Chat, we sit down with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, to discuss how blood-based biofluid testing is set to change the landscape of cancer diagnostics. 🎙️✨ buff.ly/48JuX3F #BioIVT

🔬 Expanding Access to Diagnostics 🔬 New England Biolabs is transforming diagnostics with enzyme-based tools and shelf-stable reagents, making it easier to develop tests that reach more people. Explore how NEB is making diagnostics more accessible here: buff.ly/3AtuaHe

Join Meridian Bioscience and renowned gastroenterologists Dr. Steven Moss and Dr. Colin Howden for an expert-led session on the latest H. pylori guidelines from the American College of Gastroenterology. Reserve your spot now: buff.ly/3NJnJTj #Webinar #HPylori #ACG